Lirentelimab
Lirentelimab (AK002) is a humanized anti-sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) antibody that induces apoptosis of IL-5-activated eosinophils and inhibits IL-5-mediated mast cell activation, and is used in the study of refractory inert systemic mastocytosis and allergic conjunctivitis.
Product Specifications
CAS Number
2283348-97-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Apoptosis
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3084121 100 µg
IRBIT/AHCYL1 Mouse Monoclonal Antibody (Fluoro647)
Sign In for Pricing
View Details ARP41598_P050-Biotin 100 µL
LAMP3 Antibody - N-terminal region : Biotin (ARP41598_P050-Biotin)
Sign In for Pricing
View Details